Germany
Japan
United Kingdom
China
ALK mouse monoclonal antibody, clone OTI1A4
| Applications | IHC, LMNX, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Antibodies
.jpg?d=110x100 "User supplied image")
ABCC4 Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of human ABCC4 |
Rabbit Polyclonal PD-L1 Antibody
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | PD-L1 antibody was raised against a 17 amino acid synthetic peptide from near the center of human PD-L1. The immunogen is located within amino acids 60 - 110 of PD-L1. |
Rabbit polyclonal DDR1 (Tyr513) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human DDR1 around the phosphorylation site of tyrosine 513 (P-A-YP-R-L). |
| Modifications | Phospho-specific |
Rabbit Polyclonal VLK Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | VLK antibody was raised against a 15 amino acid synthetic peptide from near the center of human VLK. The immunogen is located within amino acids 320 - 370 of VLK. |
Anti-LGR5 mouse mAb, clone OTI2A2, bionylated
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Biotin |
Rabbit Polyclonal IRAK-M Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | IRAK-M antibody was raised against a peptide corresponding to 16 amino acids near the carboxy terminus of human IRAK-M. The immunogen is located within the last 50 amino acids of IRAK-M. |
Rabbit Polyclonal Nephrin Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Nephrin antibody was raised against a 14 amino acid synthetic peptide from near the carboxy terminus of human Nephrin. The immunogen is located within the last 50 amino acids of Nephrin. |
Rabbit Polyclonal Anti-PFKFB2 Antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-PFKFB2 Antibody: A synthesized peptide derived from human PFKFB2 |
USD 379.00
In Stock
USD 428.00
In Stock
Rabbit Polyclonal Antibody against XCT
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide made to a region within the N-terminus of the human XCT protein sequence (between residues 1-50). |
USD 379.00
In Stock
Rabbit polyclonal DAPK1 Antibody (C-term)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This DAPK1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1360-1389 amino acids from the C-terminal region of human DAPK1. |
Rabbit Polyclonal Anti-HO-1 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-HO-1 Antibody: A synthesized peptide derived from human HO-1 |
Rabbit monoclonal anti-ST13 Antibody, clone OTIR191G8
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Active filters
Reactivities
- Mouse
Applications
- WB
Families
- Druggable Genome
Filter by
Target Symbol
- ALK (271)
- VSNL1 (270)
- MAP2K1 (213)
- JUN (167)
- NME1 (157)
- ERCC1 (154)
- MAP2K3 (153)
- GLI1 (144)
- CTNNB1 (135)
- ERBB2 (135)
- OTC (127)
- EGFR (124)
- ABCB1 (123)
- PIK3C2A (110)
- PCNA (105)
- AKT1 (103)
- TOP2A (98)
- MAPK13 (96)
- L1CAM (92)
- SENP2 (92)
- APP (91)
- BRAF (89)
- PNMT (87)
- TYMS (85)
- BCL2 (75)
- MLH1 (71)
- UBA52 (71)
- LOX (70)
- BCL10 (68)
- CNOT4 (68)
- NKX2-1 (68)
- SQSTM1 (67)
- F13A1 (66)
- NCAM1 (66)
- SNAI2 (66)
- STAT5A (66)
- ALDH1L1 (64)
- MAPK1 (63)
- MTOR (63)
- STAT4 (63)
- NR3C1 (62)
- PSMC3 (62)
- CDK2 (61)
- LGR5 (61)
- LPL (61)
- ABAT (60)
- PIK3CG (60)
- SOCS3 (59)
- MAPK7 (57)
- UNG (57)
- BTK (56)
- KRAS (56)
- LIMK1 (56)
- NPR3 (56)
- NRBF2 (56)
- ACAT2 (55)
- BAG5 (55)
- DPP9 (55)
- FOSB (55)
- MAPKAPK5 (55)
- PIK3AP1 (55)
- PTPRE (55)
- BECN1 (54)
- PDGFRA (54)
- PRKCE (54)
- TNNT2 (54)
- VBP1 (54)
- MCM2 (53)
- PSMD2 (53)
- KCNAB1 (52)
- LTA4H (52)
- MAPT (52)
- PFKP (52)
- PSMA6 (52)
- PSMA7 (52)
- RAB21 (52)
- RB1 (52)
- TCF12 (52)
- AKR1A1 (51)
- LDLRAP1 (51)
- PACSIN3 (51)
- PGAM2 (51)
- PPAT (51)
- PPP5C (51)
- SMAD1 (51)
- SNAP25 (51)
- TNNI3 (51)
- UBE2G2 (51)
- CDKN2C (50)
- FBXW7 (50)
- MET (50)
- NR2E3 (50)
- PCDH7 (50)
- SHPRH (50)
- TOMM34 (50)
- TRMT2A (50)
- AK4 (49)
- ESR1 (49)
- FOXO1 (49)
- SIRT5 (49)
Antibody Hosts
Isotypes
Clonalities
Conjugates
Carrier-free
Knockout (KO) Validation
Modifications
Assay Types
Pathways
- Pathways in cancer (4263)
- Metabolic pathways (3332)
- MAPK signaling pathway (2828)
- Focal adhesion (2477)
- Prostate cancer (2168)
- Neurotrophin signaling pathway (2102)
- Colorectal cancer (2038)
- ErbB signaling pathway (1977)
- Regulation of actin cytoskeleton (1716)
- T cell receptor signaling pathway (1666)
- Insulin signaling pathway (1647)
- Pancreatic cancer (1625)
- Progesterone-mediated oocyte maturation (1571)
- Toll-like receptor signaling pathway (1561)
- Endometrial cancer (1552)
- Chronic myeloid leukemia (1517)
- Glioma (1465)
- B cell receptor signaling pathway (1461)
- Melanoma (1457)
- Chemokine signaling pathway (1455)
- GnRH signaling pathway (1441)
- Non-small cell lung cancer (1439)
- Fc epsilon RI signaling pathway (1397)
- Renal cell carcinoma (1397)
- Acute myeloid leukemia (1386)
- VEGF signaling pathway (1186)
- Cell cycle (1176)
- Bladder cancer (1163)
- Wnt signaling pathway (1125)
- Gap junction (1089)
- Small cell lung cancer (1032)
- Natural killer cell mediated cytotoxicity (1031)
- Fc gamma R-mediated phagocytosis (1014)
- Adherens junction (1006)
- Leukocyte transendothelial migration (963)
- Apoptosis (913)
- Jak-STAT signaling pathway (894)
- Oocyte meiosis (894)
- Epithelial cell signaling in Helicobacter pylori infection (893)
- Melanogenesis (880)
- Endocytosis (871)
- Axon guidance (843)
- Calcium signaling pathway (815)
- Cytokine-cytokine receptor interaction (797)
- Thyroid cancer (795)
- Adipocytokine signaling pathway (792)
- Long-term potentiation (788)
- Purine metabolism (788)
- Long-term depression (765)
- Tight junction (765)
- mTOR signaling pathway (730)
- Amyotrophic lateral sclerosis (ALS) (716)
- Alzheimer's disease (698)
- Vascular smooth muscle contraction (698)
- Type II diabetes mellitus (663)
- TGF-beta signaling pathway (633)
- Neuroactive ligand-receptor interaction (592)
- Basal cell carcinoma (573)
- Pyrimidine metabolism (550)
- p53 signaling pathway (542)
- Dorso-ventral axis formation (538)
- NOD-like receptor signaling pathway (535)
- Nucleotide excision repair (532)
- Hedgehog signaling pathway (528)
- Pathogenic Escherichia coli infection (514)
- Glycolysis / Gluconeogenesis (489)
- Ubiquitin mediated proteolysis (481)
- Prion diseases (480)
- Huntington's disease (455)
- Cell adhesion molecules (CAMs) (420)
- Proteasome (419)
- RIG-I-like receptor signaling pathway (419)
- Phosphatidylinositol signaling system (407)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (386)
- Hypertrophic cardiomyopathy (HCM) (361)
- Dilated cardiomyopathy (333)
- Arginine and proline metabolism (331)
- Base excision repair (316)
- Inositol phosphate metabolism (306)
- Parkinson's disease (302)
- Valine (301)
- Mismatch repair (292)
- DNA replication (291)
- leucine and isoleucine degradation (282)
- Alanine (276)
- aspartate and glutamate metabolism (276)
- Pyruvate metabolism (273)
- Primary immunodeficiency (271)
- Tyrosine metabolism (258)
- ABC transporters (240)
- PPAR signaling pathway (232)
- Butanoate metabolism (221)
- Antigen processing and presentation (214)
- Notch signaling pathway (210)
- Propanoate metabolism (209)
- Viral myocarditis (196)
- One carbon pool by folate (191)
- Hematopoietic cell lineage (190)
- Vibrio cholerae infection (190)
- Arachidonic acid metabolism (186)
- Fatty acid metabolism (182)
- Cardiac muscle contraction (172)
- Maturity onset diabetes of the young (172)
- Drug metabolism - cytochrome P450 (170)
- Glycerolipid metabolism (170)
- Complement and coagulation cascades (168)
- Fructose and mannose metabolism (167)
- Pentose phosphate pathway (158)
- SNARE interactions in vesicular transport (149)
- ECM-receptor interaction (148)
- Lysine degradation (147)
- Cytosolic DNA-sensing pathway (143)
- Metabolism of xenobiotics by cytochrome P450 (143)
- Tryptophan metabolism (143)
- Glutathione metabolism (142)
- Lysosome (139)
- RNA degradation (137)
- Retinol metabolism (136)
- beta-Alanine metabolism (135)
- Citrate cycle (TCA cycle) (130)
- Drug metabolism - other enzymes (129)
- Starch and sucrose metabolism (122)
- Ribosome (116)
- Type I diabetes mellitus (116)
- Renin-angiotensin system (112)
- Galactose metabolism (110)
- Circadian rhythm - mammal (107)
- Histidine metabolism (106)
- Glycine (105)
- serine and threonine metabolism (105)
- Oxidative phosphorylation (101)
- Amino sugar and nucleotide sugar metabolism (98)
- Olfactory transduction (97)
- Spliceosome (97)
- Methane metabolism (93)
- Regulation of autophagy (93)
- Homologous recombination (92)
- Basal transcription factors (79)
- Phenylalanine metabolism (78)
- Porphyrin and chlorophyll metabolism (75)
- Synthesis and degradation of ketone bodies (75)
- Folate biosynthesis (72)
- Cysteine and methionine metabolism (68)
- Terpenoid backbone biosynthesis (67)
- Systemic lupus erythematosus (63)
- Sphingolipid metabolism (55)
- Non-homologous end-joining (51)
- Glyoxylate and dicarboxylate metabolism (49)
- Taste transduction (49)
- Sulfur metabolism (46)
- Ether lipid metabolism (45)
- Other glycan degradation (42)
- Nitrogen metabolism (40)
- Autoimmune thyroid disease (37)
- Caffeine metabolism (37)
- Allograft rejection (36)
- Selenoamino acid metabolism (34)
- Glycerophospholipid metabolism (33)
- Graft-versus-host disease (33)
- Glycosaminoglycan degradation (31)
- Pantothenate and CoA biosynthesis (31)
- Riboflavin metabolism (31)
- Androgen and estrogen metabolism (30)
- Fatty acid biosynthesis (30)
- Limonene and pinene degradation (29)
- Taurine and hypotaurine metabolism (29)
- Primary bile acid biosynthesis (27)
- leucine and isoleucine biosynthesis (27)
- Ascorbate and aldarate metabolism (25)
- Fatty acid elongation in mitochondria (23)
- Thiamine metabolism (22)
- Steroid biosynthesis (16)
- Aminoacyl-tRNA biosynthesis (15)
- Pentose and glucuronate interconversions (15)
- Phenylalanine (14)
- Vitamin B6 metabolism (14)
- tyrosine and tryptophan biosynthesis (14)
- Nicotinate and nicotinamide metabolism (12)
- Linoleic acid metabolism (11)
- Asthma (10)
- Biosynthesis of unsaturated fatty acids (10)
- Protein export (10)
- N-Glycan biosynthesis (9)
- Glycosphingolipid biosynthesis - ganglio series (8)
- Ubiquinone and other terpenoid-quinone biosynthesis (6)
- C21-Steroid hormone metabolism (5)
- O-Glycan biosynthesis (4)
- RNA polymerase (4)
- Glycosphingolipid biosynthesis - lacto and neolacto series (3)
- Heparan sulfate biosynthesis (3)
- alpha-Linolenic acid metabolism (3)
- Glycosphingolipid biosynthesis - globo series (2)
- Chondroitin sulfate biosynthesis (1)
- D-Arginine and D-ornithine metabolism (1)
- Keratan sulfate biosynthesis (1)